Clinical Trial Update: "Lactobacillus Crispatus M247, LSIL and Microbiota" [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update investigating Lactobacillus crispatus M247 for vaginal flora imbalance, ASC-US/LSIL, and HPV infection is listed with an unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asc-us
• Hpv Infection
• Lsil
• Vaginal Flora Imbalance

Drugs mentioned

• Lactobacillus crispatus M247

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Vaginal Flora Imbalance, ASC-US | Phase 4 | Status: UNKNOWN